ArticleTranslational animal science2026
Effect of S-abscisic acid supplementation on the growth performance and antioxidant status of nursery pigs.
Article in Translational animal science, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
13 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
A total of 320 nursery pigs (DNA 241 × 600; initially 5.4 ± 0.52 kg) were used to evaluate the effect of dietary S-abscisic acid (S-ABA) supplementation on the growth performance and antioxidant status of pigs. Pigs were weaned at approximately 18 d of age and assigned to pens in generalized randomized block design with sex and weight category as blocking factors. Pigs were fed a common phase 1 diet for 7 d postweaning. On d 7 post-weaning, pen of pigs (6.4 ± 0.57 kg) within sex × weight blocks were randomly allotted to 1 of 4 dietary treatments. Treatments included a conventional nursery diet (Control) and 3 diets which used the Control formulation with increasing S-ABA (0.5, 1.0 and 5.0 mg/kg). Treatments were provided during phases 2 (d 0 to 14) and 3 (d 14 to 35). Growth performance was measured weekly. Additionally, 32 pigs on d 0 and 2 pigs per pen on d 14 and 35 were bled to assess the erythrocytes' total glutathione (GSH + GSSG), reduced glutathione (GSH), oxidized to reduced glutathione ratio (GSSG:GSH), and serum total antioxidant capacity (TAC), superoxide dismutase (SOD), and thiobarbituric acid reactive substances (TBARS). At the termination of the trial, 2 pigs in each pen were euthanized and duodenal, jejunal, and ileal mucosa were collected to measure GSH + GSSG, GSH and GSSG:GSH. No interactive effects between S-ABA and sex on growth performance were observed. Additionally, increasing S-ABA did not influence growth performance. There were also no interactions between S-ABA and collection day on antioxidant parameters. Erythrocyte GSH + GSSG tended to increase (linear,
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.